Vivo Bio Tech Reports Strong Q1 FY2026 Performance with 29.66% Revenue Growth
Vivo Bio Tech Limited announced robust Q1 FY2026 results. Total income increased by 29.66% to Rs. 2,220.72 lakhs. Profit After Tax rose by 21.93% to Rs. 155.72 lakhs. Earnings Per Share improved to Rs. 1.05. Operating Profit Margin increased to 9.04%. The company published its un-audited financial results in English and Telugu newspapers on August 14, 2025.
04Aug 25
Vivo Bio Tech Shareholders Approve Increase in Authorized Share Capital
Vivo Bio Tech Limited secured shareholder approval to increase its authorized share capital and alter the Capital Clause of its Memorandum of Association. The resolution passed with 99.81% votes in favor, with a 31.47% overall participation rate. The Promoter and Promoter Group showed 100% support with a 68.78% participation rate. This approval could enable the company to raise additional funds, potentially for growth strategies or expansion plans.